Founded in 1975, Cystic Fibrosis Research Institute (CFRI) seeks to be a global resource for the cystic fibrosis community while pursuing a cure through research, education, advocacy, and support. We serve those living with or affected by cystic fibrosis (CF), a life-shortening, progressive genetic disease known for its respiratory impacts but which impacts all major organs. CFRI provides cystic fibrosis scientific research grants through two programs. The New Horizons Program funds principal investigators (PI) at medical and academic institutions across the nation for two-year projects. The program endeavors to fund those applications with the greatest relevance to finding improved treatments or a cure for CF. The Elizabeth Nash Fellowship Program funds post-doctoral fellows nationwide for two-year projects, and encourage collaborative research and communication between the institutions and PI’s. Through its Patrick Nash CF Fellows Training Program, CFRI seeks to develop a multidisciplinary model of care for adults with CF. Selected fellows representing a wide range of medical disciplines participate in an annual symposium, quarterly meetings to encourage collaborative research, and work with expert mentors. Applications for the 2025 program are available March 1 through May 31. In addition to supporting CF research, CFRI provides educational, psychosocial, and advocacy programs and services to those with CF and their families, caregivers, and healthcare professionals. Living with CF is challenging physically, emotionally and financially. We provide resources that address the multi-faceted needs of the CF community while increasing awareness of CF through outreach and advocacy activities.
CHILDREN’S HEALTH
Children’s Health℠ is the leading pediatric healthcare system in North Texas and has long been recognized as a leader in pediatric health. Children’s Health campuses include Children’s Medical Center Dallas, Children’s Medical Center Plano, and multiple Children’s Health Specialty Centers. With its academic partner, UT Southwestern, Children’s Medical Center Dallas is consistently ranked #1 children’s hospital in North Texas and among the nation’s best pediatric hospitals by U.S. News & World Report. Its commitment to excellence and providing outstanding care across all aspects of pediatrics has resulted in 11 out of 11 specialty programs being ranked among the best for six consecutive years, including Cancer, Cardiology & Heart Surgery, Diabetes & Endocrinology, Gastroenterology & GI Surgery, Neonatology, Nephrology, Neurology & Neurosurgery, Orthopedics, Pulmonology, Urology, and Behavioral Health.
Boston Medical Products
Boston Medical Products is the exclusive US distributor of NOVATECH brand products, such as the DUTAU® Rigid Bronchoscope, ROTEPS® Bronchoscopy Forceps, TONN™ stent applicators, SURVAC™ Suction Catheters, DUMON® stents and STERITALC®, (talc) powder, for intrapleural use, indicated to decrease recurrence of malignant pleural effusions and pneumothorax. ATS 2025 will be the OFFICIAL launch of the DUTAU® Rigid Bronchoscope as well as featuring the ROTEPS® Bronchoscopy Forceps.
Alveolar Capillary Dysplasia Association (ACDA)
Alveolar Capillary Dysplasia with misalignment of the pulmonary veins (ACDMPV) results in an infant fatality in almost every occurrence due to the inability of the lungs to effectively deliver oxygen to the bloodstream. The ACDA is dedicated to increasing ACDMPV awareness and funding ACDMPV research in the medical community. Searching For Answers…Hoping for a Cure.